Short answer
TransMedics Group, Inc. (TMDX) filed an 8-K current report with the SEC on February 27, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q4 2025 results impacted by release of U.S. valuation allowance on deferred tax assets: a non-cash but significant accounting event.
TransMedics Group, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q4 2025 results impacted by release of U.S. valuation allowance on deferred tax assets: a non-cash but significant accounting event
- Valuation allowance release signals management's increased confidence in future profitability, boosting reported net income
- Clarification filing suggests the tax benefit materially altered previously reported Q4 2025 figures: full detail in Exhibit 99.1
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other TransMedics Group, Inc. 8-K filings
Get the next TMDX 8-K as it lands
Follow TMDX for push alerts, or ask the research agent what this filing means.